From cutting dementia risk to reducing opioid addiction, a wave of 2025-2026 studies reveals that drugs like Ozempic and Wegovy may be the most versatile medications in a generation.
Three WHO-commissioned systematic reviews analyzed GLP-1 drugs across 44,000+ participants. The findings go well beyond the scale. Here's what matters.
GLP-1 medications like Ozempic increase muscle loss risk. Learn the protein timing strategy that protects lean mass while maximizing fat loss.
From next-generation GLP-1 medications to continuous glucose monitors and AI apps, discover the science-backed technologies reshaping weight management in 2025.
GLP-1 agonists like Ozempic reduce appetite dramatically, but without proper nutrition, muscle loss and deficiencies follow.
From personalized nutrition stacks to GLP-1 support formulas, discover which 2025 supplement trends have real science behind them and which are just marketing.
